3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Primary Malignant Peripheral Nerve Sheath Tumors
1
Precursor Cell Lymphoblastic Leukemia-Lymphoma
1
Myelodysplastic Syndromes
1
Mycosis Fungoides
1
Lymphoma, T-Cell, Cutaneous
1
Leukemia, Myelomonocytic, Chronic
1
GATA2 Deficiency
1
Anemia, Refractory, with Excess of Blasts
1
Interventions
Magnetic Resonance Spectroscopy
3
Cyclophosphamide
3
ulixertinib
2
tipifarnib
2
selpercatinib
2
ivosidenib
2
X-Rays
2
Vincristine
2
Temozolomide
2
Specimen Handling
2
Radiation
2
Phantoms, Imaging
2
Nuclear Medicine Department, Hospital
2
Ifosfamide
2
Etoposide
2
Eflornithine
2
Doxorubicin
2
Congresses as Topic
2
trifluridine tipiracil drug combination
1
tazemetostat
1
talazoparib
1
palbociclib
1
olaparib
1
liposomal doxorubicin
1
larotrectinib
1
irinotecan sucrosofate
1
ganitumab
1
fludarabine phosphate
1
fludarabine
1
etoposide phosphate
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Sarcoma, Ewing
×
Vorinostat
×
30 days
×
Clear all
No trials found.